| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ACC
|
1,276.50 | 239.7B | 17.66 | 1.17 | 6.89 | 5.7% | 14.7% | 66 | 41 | 2,309.87 | +58.3% | 91 | 0.03 |
|
AMBUJACEM
|
401.15 | 996.8B | 26.49 | 1.68 | 12.66 | 3.1% | 13.7% | 55 | 28 | 479.63 | +14.1% | 85 | 0.01 |
|
INDIACEM
|
370.65 | 114.9B | — | 1.13 | 37.12 | 0.1% | 14.9% | 51 | 25 | 615.89 | +33.7% | 44 | 0.13 |
|
RAMCOCEM
|
879.55 | 207.8B | 25.09 | 2.57 | 12.37 | 4.5% | 13.9% | 49 | 28 | 843.11 | -2.8% | 55 | 0.48 |
|
GRASIM
|
3,371.00 | 2,294.2B | 38.99 | 2.22 | 16.76 | 4.2% | 7.5% | 47 | 42 | 3,245.98 | -2.5% | 44 | 2.20 |
|
SHREECEM
|
23,200.00 | 837.1B | 43.75 | 3.60 | 14.91 | 6.9% | 13.7% | 40 | 24 | 16,727.14 | -20.1% | 80 | 0.08 |
|
ULTRACEMCO
|
11,450.00 | 3,368.0B | 36.43 | 4.40 | 19.08 | 10.5% | 13.3% | 40 | 28 | 7,964.89 | -22.8% | 65 | 0.31 |
|
JKCEMENT
|
5,133.00 | 396.5B | 35.75 | 5.63 | 16.13 | 11.5% | 13.5% | 36 | 30 | 3,495.08 | -23.9% | 63 | 0.88 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.